Multi-Omics in Biomarker Discovery & Precision Medicine
Online Symposium
12 November 2024 | Online, GMT (UTC+0)
Bringing together key opinion leaders from across the globe for focused discussions on utilising multi-omics approaches in biomarkers discovery & precision medicine
Sponsored By
NanoString, a Bruker company, is a leader in spatial biology offering an ecosystem of innovative discovery and translational research tools that empower scientists to map the universe of biology. The GeoMx® Digital Spatial Profiler is a flexible reliable solution, combining the power of whole tissue imaging with gene expression and protein data for spatial whole transcriptomics and proteomics. The CosMx™ Spatial Molecular Imager is a single-cell imaging platform powered by spatial multiomics enabling researchers to map single cells in their native environments to extract deep biological insights and novel discoveries from one experiment. The AtoMx™ Spatial Informatics Platform is a cloud-based informatics solution with advanced analytics and global collaboration capabilities, enabling powerful spatial biology insights anytime, anywhere. At the foundation of our research tools is our nCounter® Analysis System which offers a secure way to easily profile the expression of hundreds of genes, proteins, miRNAs, or copy number variations, simultaneously with high sensitivity and precision. For more information, please visit www.nanostring.com.
Key Topics Covered
- Best practice multi-omics approaches for advanced biomarker discovery:
» Proteomics
» Transcriptomics - Incorporating immunoprofiling into omics-based approaches
- Spatial multi-omics in biomarker discovery research
- Integrating biomarker discovery into drug discovery processes
- Multi-omics analysis in precision medicine
Benefits of Attending
- Meet with global key innovators in a focused symposium to hear the latest case studies in utilizing multi-omics for biomarker discovery & precision medicine. This programme takes a deep dive into best practice multi-omics approaches & technological advancements, bringing together thought leaders from across the globe for focused discussions & networking
- Stay at the forefront of innovation by hearing about the latest methods & strategies of integrating spatial multi-omics in biomarker discovery research
- Discuss the latest advancements in multi-omics analysis in precision medicine
- Followed by the release of the ‘Harnessing Biomarker Discovery & Precision Medicine with Multi-Omics-Based Approaches’ report detailing key insights, methodologies,
and emerging trends discussed during the event for leveraging biomarkers discovery effectively
Oxford Global's online symposiums serve as hubs for professionals to connect, share knowledge, and inspire innovation. By bringing together experts from all geographies, we create dynamic environments where cutting-edge ideas are exchanged and boundaries are pushed. Our symposiums are highly focused, delving deep into specific topics to provide valuable insights and expertise. Through collaborative discussions and forward-thinking initiatives, we inspire new approaches and drive progress in life sciences. Join us to be part of this transformative journey towards groundbreaking discoveries and solutions!
Latest Resources
GHR Foundation Commits $15m to C2N Diagnostics for Tau Tangle Pathology Test for Diagnosing, Staging Alzheimer’s Disease
GHR’s total investment in C2N has now broken $50 million since 2020.
Study Analyses Predictive Biomarkers for COVID-19 ICU Patient Mortality
The study from the Federal University of Paraíba, Brazil analyses a series of haematological, biochemical, and inflammatory factors all contribute to the mortality of COVID-19 patients in the ICU.
Group Identify Prognostic Biomarker for SCLC and Treatment Using Chemotherapy
SCLC patients that express the gene PCDHB4 have a higher likelihood of developing a resistance to chemotherapy.
Proteomic Analysis of Serum Extracellular Vesicles Reveals Potential Biomarkers for Neuroblastoma
The proteomic analysis of extracellular vesicles is shaping up to be a promising biomarker discovery technique for diseases like neuroblastoma.
Blood Biomarkers Signal Increased Risk of Alzheimer's & MND After Multiple Rugby Concussions
Results that show rugby players that have sustained multiple concussions present with markers of neurodegenerative disease development.
Life Science Players Join €23m European Project for Precision Medicine, PRECISEU
The project will bring together life science institutions across European nations in the interest of expanding development of and access to advanced therapy medicinal products.
Meet Our Expert Speakers
Multi-Omics in Biomarker Discovery & Precision Medicine Online Symposium again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative, data and industry outlooks.
Confirmed speakers include:
Claudia Fredolini
Head of unit,
Affinity Proteomics-Stockholm Unit; KTH-Royal Institute of Technology
Jia Guo
Associate Professor,
Arizona State University
Manuel Salto-Tellez
Professor,
The Institute of Cancer Research
Priyank Patel
Senior scientist,
www.boehringer-ingelheim.com
Register Your Interest
Submit your details and a member of our team will be in touch